ENTEROSYS

info

  • About

    ENTEROSYS' strategy is to develop therapeutic peptides that trigger the intestinal brain without entering the body avoiding systemic deleterious impacts related to non specific and systemic actions.

  • Join the move

    ENTEROSYS has joined the move since 29/11/2018.

  • Cash Invested

    TEMA has invested 3.000€ in ENTEROSYS.

Know more about enterosys

A smart therapeutic peptide based company. The gut is a major heatlh driver since it has its own « brain: the second brain »!. The scientists discovered that in the luminal side of the gut numerous small peptides are released that control the « second brain ». They uncovered the intimate molecular mechanisms of that brain which controls numerous physiological functions thereby improving health.

 

Enterosys strategy is to develop therapeutic peptides that trigger the intestinal brain without entering the body avoiding systemic deleterious impacts related to non specific and systemic actions. This novel strategy should dramatically reduce the amount of pharmaceutical molecules requires to be efficient. Hence less molecules produced and released in the Nature. The use of natural peptides as drugs targeting the gut should be safe and more efficient : a better solution for treating diseases. We do believe at TEMA that this first in line strategy will help reduce too numerous chemical based strategies.